Impact of the Covid-19 pandemic on primary care utilization: evidence from Sweden using national register dataResearch Note Published on 2021-11-242022-10-27 Journal: BMC Research Notes [Category] Coronavirus, MERS, SARS, [키워드] age changes in Contact COVID-19 Evidence finding First wave groups Impact men and women MONITOR National objective occurred pandemic Patient patient groups primary care reduced reduction reductions in Research Result service delivery stratified by sex supplementary material Sweden Swedish were used [DOI] 10.1186/s13104-021-05839-7 PMC 바로가기 [Article Type] Research Note
COVID-19 pandemic and waiting times in outpatient specialist care in Germany: an empirical analysisResearch Article Published on 2021-10-112022-10-28 Journal: BMC health services research [Category] COVID-19, MERS, SARS, [키워드] Analysis analyzed average Care caused collected conducted Corona COVID-19 COVID-19 infection COVID-19 pandemic Data analysis Effect Effects evaluate exacerbate example exceptional experiment Germany Health Health Service healthcare healthcare access Healthcare provider Healthcare system inequalities inequality lack less linear mandatory outcome Outpatient pandemic Patient patient group patient groups Physicians Probability public health receiving reduction Region remained Result resulting second significantly increased specialist strained Waiting time [DOI] 10.1186/s12913-021-07094-9 PMC 바로가기 [Article Type] Research Article
Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients동종 줄기 세포 이식 환자에서 SARS-Cov-2 백신 1회 접종 후 혈청학적 반응Article Published on 2021-10-012022-09-12 Journal: Transplantation and cellular therapy [Category] MERS, SARS, 진단, [키워드] Administered Allogeneic Allogeneic stem cell transplantation Antibody Response AstraZeneca AZ vaccine Cell cell transplantation Cohort COVID COVID vaccination healthy Hematologic malignancy highlight immunogenic Immunosuppression Immunosuppressive medication individual lack measure mounted mRNA vaccines Older age Patient patient groups patients Pfizer-BioNTech PROTECT recipient recipients response SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antibody response. SARS-CoV-2 vaccine serologic significantly single dose solid organ transplantation STEM transplantation Trial vaccination Vaccine [DOI] 10.1016/j.jtct.2021.07.011 PMC 바로가기 [Article Type] Article
The serum amino acid profile in COVID-19COVID-19의 혈청 아미노산 프로필Clinical Trial Published on 2021-10-012022-09-11 Journal: Amino acids [Category] MERS, SARS, 바이오마커, 비임상, 임상, 치료기술, [키워드] addition Affect Amino acid amino acid metabolism amino acids BCAA BCAAs Biomarker branched-chain amino acid branched-chain amino acids breath can be used caused changed conducted control group coronavirus coronavirus disease correlation Course COVID patient Covid patients COVID-19 COVID-19 patient COVID-19 patients Determining develop Diagnosis Diseases examined group healthy Impact Infection information l-2-aminobutyric acid. L-phenylalanine Laboratory metabolism Mild moderate pandemic patient groups patients with asymptomatic Phenylalanine profile Prognosis prognostic SARS-CoV-2 SARS-COV-2 infection serum severity significant difference significant differences statistical analyses statistical analysis subject Taurine the disease Treatment treatment protocols [DOI] 10.1007/s00726-021-03081-w PMC 바로가기 [Article Type] Clinical Trial
TIM‐3 as a potential exhaustion marker in CD4 + T cells of COVID‐19 patientsCOVID-19 환자의 CD4 + T 세포에서 잠재적인 피로 마커로서의 TIM-3Original Article Published on 2021-09-092022-09-10 Journal: Immunity, Inflammation and Disease [Category] SARS, 치료기술, [키워드] Blood Blood urea nitrogen C‐reactive protein calculated cause CD39 CD4 clinical information clinical symptom Clinical symptoms collected COVID‐19 COVID‐19 patient COVID‐19 patients COVID‐19 creatinine Critical critical patients deaths disease erythrocyte sedimentation erythrocyte sedimentation rate evaluate evaluated Exhausted cell flow cytometry group groups healthy individuals in healthy individual laboratory data lymphocyte Lymphocytes lymphopenia marker Mild mononuclear cell mononuclear cells neutrophil neutrophil count nitrogen occur overexpression Patient patient groups PBMCs PD‐1 PD‐1 peripheral Peripheral blood Peripheral blood mononuclear cells Result sedimentation rate significant difference significantly higher subjects subpopulation T cell T cells TIM‐3 urea [DOI] 10.1002/iid3.526 PMC 바로가기 [Article Type] Original Article
Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia인간 비강 상피에서 주요 SARS-CoV-2 진입 인자의 연령 및 기도 질환 관련 유전자 발현 패턴Article Published on 2021-09-012022-09-11 Journal: Virology [Category] SARS, 바이오마커, [키워드] ACE2 Affect age AGTR2 airway biopsy caused Course COVID-19 pandemic differential expression disease disease course downregulation epithelia examined expression of SARS-CoV-2 Factor Gene Expression gene expression pattern inverse correlation mucosal nasal NRP1 Patient patient groups SARS-CoV-2 SARS-CoV-2 entry factor SARS-CoV-2 entry factors susceptibility the disease TMPRSS2 underlie [DOI] 10.1016/j.virol.2021.05.012 PMC 바로가기 [Article Type] Article
Rarely Recognized Antibody Diversification in Covid-19 Evolution to Counteract Advanced SARS-CoV-2 Evasion Strategies, and Implications for Prophylactic TreatmentPhysiology Published on 2021-08-032022-10-31 Journal: Frontiers in Physiology [Category] COVID-19, [키워드] adaptive Amino acid amino-acid sequence dependency antibody antibody diversification B-cell candidate component consequence COVID-19 Critical defined determinant disease effective elicited epitope vaccines Evidence Evolution example explain gene sequence Genome glycosylation help highlight human cell humoral immune response hypothese immune response immune system Immunity immunogenic peptides immunomodulatory effects Implications Interpretation mechanism natural infection neutralizing antibody pandemic patient groups platform post-translational modification prophylactic treatment rarely recognized immune responses Safe SARS-CoV-2 SARS-COV-2 infection sequence somatic mutations Structural variation the vaccine translational Trial unique Vaccine design virus [DOI] 10.3389/fphys.2021.624675 PMC 바로가기 [Article Type] Physiology
Telehealth in Australian cardiology: insight into factors predicting the use of telephone versus video during the COVID-19 pandemicObservational Study Published on 2021-08-012022-10-05 Journal: Internal medicine journal [Category] SARS, 임상, [키워드] Ambulatory care cardiac Cardiology Characteristics conducted Consulting contributing to COVID-19 COVID-19 pandemic cross demographic Factor female healthcare hospital identify Melbourne Mortality no difference Older outcome outcomes Outpatient Patient patient groups platform Pragmatic telehealth Telemedicine translate variable Volume [DOI] 10.1111/imj.15444 PMC 바로가기 [Article Type] Observational Study
Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients실험실 마커의 종 방향 모니터링은 입원 및 외래 Covid-19 환자를 특징으로합니다.Article Published on 2021-07-142022-09-10 Journal: Scientific Reports [Category] SARS, 바이오마커, 임상, 진단, 치료기술, 치료법, [키워드] acute phase Admission ambulatory patient ambulatory patients C-reactive protein cardiac cardiac troponin Cardiac troponin I Clinical course COVID-19 COVID-19 patient COVID-19 patients Critically ill critically ill COVID-19 patients CRP D-dimer determine Diagnostic markers Early detection ferritin form home quarantine Hospitalized hospitalized patient hospitalized patients Human IL-6 IL-6 level IL-6 levels interleukin interleukin-6 Laboratory longitudinal marker mild COVID-19 patient moderate moderate to severe myocardial injury on admission Patient patient groups patients positive Predictive Predictive markers Prognosis Prognostic markers recruitment SARS-CoV-2 severe forms of COVID-19 significant decrease troponin I were measured [DOI] 10.1038/s41598-021-93950-x PMC 바로가기 [Article Type] Article
Case Management of COVID-19 (Secondary Version)Review Article: COVID-19 Published on 2021-07-092022-10-30 Journal: JMA Journal [Category] COVID-19, [키워드] Anxiety clinical trials COVID-19 Dexamethasone disease disease severity drug therapy effective Efficacy evaluated example Healthcare system identify Laboratory management marker Medical resources Patient patient groups reduce Remdesivir Repurposed drug secondary selected severe cases severe disease severity Standard therapy Steroids Tocilizumab Version [DOI] 10.31662/jmaj.2021-0036 PMC 바로가기 [Article Type] Review Article: COVID-19